We demonstrated that upregulation NPL4 binds directly to DXO and induces its degradation, whereas DXO regulates bladder cancer cell proliferation via destabilization of cyclin D1 mRNA. The gene discussed is CCND1; the disease is urinary bladder carcinoma.